Extrahepatic manifestations of chronic hepatitis C virus infection
Open accessThe DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Abstract
During hepatitis C virus (HCV) chronic infection, extrahepatic manifestations are frequent and polymorphous. This article reports on a large cohort of patients with HCV-related autoimmune or lymphoproliferative disorders, from mixed cryoglobulinemia vasculitis to frank lymphomas. The relationship between HCV infection and such immune-related diseases has been formally demonstrated by epidemiological, clinical, immunological and pathological data, and results of therapeutic trials. More recently, other nonliver-related HCV disorders have been reported, including cardiovascular (i.e. stroke, ischemic heart disease), renal, metabolic and central nervous system diseases. For these manifestations, most evidence comes from large epidemiological studies; there is a need for mechanistic studies and therapeutic trials for confirmation. Beyond the risk of developing liver complications, that is, cirrhosis and liver cancer, patients with HCV infection have an increased risk of morbidity and mortality related to nonliver diseases. HCV chronic infection should be analyzed as a systemic disease in which extrahepatic consequences increase the weight of its pathological burden. The need for effective viral eradication measures is underlined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,178
Binding of Hepatitis C Virus to CD81
Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G., et al. (1998) · Science · doi:10.1126/science.282.5390.938 · Cited by 2,066
Peck, M., Craxì, A., Fried, M., & Zeuzem, S. (2013) · Cited by 1,079
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.003 · Cited by 855
Hermine, O., Lefrère, F., Bronowicki, J.-P., Mariette, X., Jondeau, K., Eclache-Saudreau, V., Delmas, B., Valensi, F., Cacoub, P., Brechot, C., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013376 · Cited by 807
Self-citationShintani, Y., Fujie, H., Miyoshi, H., Tsutsumi, T., Tsukamoto, K., Kimura, S., Moriya, K., & Koike, K. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.056 · Cited by 763
Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
Saadoun, D., Rosenzwajg, M., Joly, F., Six, A., Carrat, F., Thibault, V., Sene, D., Cacoub, P., & Klatzmann, D. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105143 · Cited by 762
Self-citationAssociation of Diabetes Mellitus and Chronic Hepatitis C Virus Infection
Mason, A. L., Lau, J. Y., Hoang, N., Qian, K., Alexander, G. J., Xu, L., Guo, L., Jacob, S., Regenstein, F. G., Zimmerman, R., et al. (1999) · Hepatology · doi:10.1002/hep.510290235 · Cited by 659
Extrahepatic manifestations of chronic hepatitis C
Cacoub, P., Poynard, T., Ghillani, P., Charlotte, F., Olivi, M., Charles Piette, J., Opolon, P., & for the MULTIVIRC GROUP (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199910)42:10<2204::aid-anr24>3.0.co;2-d · Cited by 648
Self-citationInterferon Alfa-2a Therapy in Cryoglobulinemia Associated with Hepatitis C Virus
Misiani, R., Bellavita, P., Fenili, D., Vicari, O., Marchesi, D., Sironi, P. L., Zilio, P., Vernocchi, A., Massazza, M., Vendramin, G., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403173301104 · Cited by 583
Stabilization of atherosclerotic plaques: New mechanisms and clinical targets
Libby, P., & Aikawa, M. (2002) · Nature Medicine · doi:10.1038/nm1102-1257 · Cited by 580
Cacoub, P., Renou, C., Rosenthal, E., Cohen, P., Loury, I., Loustaud-Ratti, V., Yamamoto, A.-M., Camproux, A.-C., Hausfater, P., Musset, L., et al. (2000) · Medicine · doi:10.1097/00005792-200001000-00005 · Cited by 565
Self-citationLee, M.-H., Yang, H.-I., Lu, S.-N., Jen, C.-L., You, S.-L., Wang, L.-Y., Wang, C.-H., Chen, W. J., Chen, C.-J., & for the R.E.V.E.A.L.-HCV Study Group (2012) · Journal of Infectious Diseases · doi:10.1093/infdis/jis385 · Cited by 554
Kawaguchi, T., Yoshida, T., Harada, M., Hisamoto, T., Nagao, Y., Ide, T., Taniguchi, E., Kumemura, H., Hanada, S., Maeyama, M., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63408-6 · Cited by 536
Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients
Ferri, C., Sebastiani, M., Giuggioli, D., Cazzato, M., Longombardo, G., Antonelli, A., Puccini, R., Michelassi, C., & Zignego, A. L. (2004) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2003.10.001 · Cited by 528
Inflammation and Infections as Risk Factors for Ischemic Stroke
Lindsberg, P. J., & Grau, A. J. (2003) · Stroke · doi:10.1161/01.str.0000089015.51603.cc · Cited by 519
A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C
Backus, L. I., Boothroyd, D. B., Phillips, B. R., Belperio, P., Halloran, J., & Mole, L. A. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.004 · Cited by 481
Allison, M. E. D., Wreghitt, T., Palmer, C. R., & Alexander, G. J. M. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80631-2 · Cited by 454
Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease
Forton, D. M., Thomas, H. C., Murphy, C. A., Allsop, J. M., Foster, G. R., Main, J., Wesnes, K. A., & Taylor-Robinson, S. D. (2002) · Hepatology · doi:10.1053/jhep.2002.30688 · Cited by 450
Rituximab as First-Line and Maintenance Therapy for Patients With Indolent Non-Hodgkin’s Lymphoma
Hainsworth, J. D., Litchy, S., Burris, H. A., Scullin, D. C., Corso, S. W., Yardley, D. A., Morrissey, L., & Greco, F. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.674 · Cited by 416
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis
De Vita, S., Quartuccio, L., Isola, M., Mazzaro, C., Scaini, P., Lenzi, M., Campanini, M., Naclerio, C., Tavoni, A., Pietrogrande, M., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34331 · Cited by 405
Bonkovsky, H. L., & Woolley, M. J. (1999) · Hepatology · doi:10.1002/hep.510290124 · Cited by 398
Caronia, S., Taylor, K., Pagliaro, L., Carr, C., Palazzo, U., Petrik, J., O'Rahilly, S., Shore, S., Tom, B. D., & Alexander, G. J. M. (1999) · Hepatology · doi:10.1002/hep.510300416 · Cited by 396
(2008) · Kidney International · doi:10.1038/ki.2008.81 · Cited by 377
Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon α with an anti-CD20
Sansonno, D., De Re, V., Lauletta, G., Tucci, F. A., Boiocchi, M., & Dammacco, F. (2003) · Blood · doi:10.1182/blood-2002-10-3162 · Cited by 370
De Sanjose, S., Benavente, Y., Vajdic, C. M., Engels, E. A., Morton, L. M., Bracci, P. M., Spinelli, J. J., Zheng, T., Zhang, Y., Franceschi, S., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.011 · Cited by 338
Seeff, L. B., Hollinger, B. F., Alter, H. J., Wright, E. C., Cain, C. M. B., Buskell, Z. J., Ishak, K. G., Iber, F. L., Toro, D., Samanta, A., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.21905 · Cited by 321
Extrahepatic manifestations of hepatitis C among United States male veterans
El-Serag, H. B., Hampel, H., Yeh, C., & Rabeneck, L. (2002) · Hepatology · doi:10.1002/hep.1840360621 · Cited by 314
Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy: Prevalence and Prediction
Raison, C. L., Borisov, A. S., Broadwell, S. D., Capuron, L., Woolwine, B. J., Jacobson, I. M., Nemeroff, C. B., & Miller, A. H. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0106 · Cited by 299
Dal Maso, L., & Franceschi, S. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0308 · Cited by 297
Hsu, Y.-C., Lin, J.-T., Ho, H. J., Kao, Y.-H., Huang, Y.-T., Hsiao, N.-W., Wu, M.-S., Liu, Y.-Y., & Wu, C.-Y. (2014) · Hepatology · doi:10.1002/hep.26892 · Cited by 277
Hepatitis C Virus Infection and the Risk of Coronary Disease
Butt, A. A., Xiaoqiang, W., Budoff, M., Leaf, D., Kuller, L. H., & Justice, A. C. (2009) · Clinical Infectious Diseases · doi:10.1086/599371 · Cited by 276
High Prevalence of Hepatitis C Virus Infection in Diabetic Patients
Simó, R., Hernández, C., Genescà, J., Jardí, R., & Mesa, J. (1996) · Diabetes Care · doi:10.2337/diacare.19.9.998 · Cited by 275
Vallisa, D., Bernuzzi, P., Arcaini, L., Sacchi, S., Callea, V., Marasca, R., Lazzaro, A., Trabacchi, E., Anselmi, E., Arcari, A. L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.008 · Cited by 263
Zignego, A. L., Ferri, C., Pileri, S. A., Caini, P., & Bianchi, F. B. (2007) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.06.008 · Cited by 262
Natural history of acute and chronic hepatitis C
Maasoumy, B., & Wedemeyer, H. (2012) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2012.09.009 · Cited by 257
Fatigue in patients with chronic hepatitis C
Poynard, T., Cacoub, P., Ratziu, V., Myers, R. P., Dezailles, M. H., Mercadier, A., Ghillani, P., Charlotte, F., Piette, J. C., Moussalli, J., et al. (2002) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2002.00364.x · Cited by 247
Self-citationSneller, M. C., Hu, Z., & Langford, C. A. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34322 · Cited by 236
Boyer, O., Saadoun, D., Abriol, J., Dodille, M., Piette, J.-C., Cacoub, P., & Klatzmann, D. (2004) · Blood · doi:10.1182/blood-2003-07-2598 · Cited by 223
Self-citationDepression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors
Golden, J., O'Dwyer, A. M., & Conroy, R. M. (2005) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2005.06.006 · Cited by 211
McHutchison, J. G., Ware, J. E., Bayliss, M. S., Pianko, S., Albrecht, J. K., Cort, S., Yang, I., & Neary, M. P. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00026-x · Cited by 210
Zignego, A. L., Ferri, C., Giannelli, F., Giannini, C., Caini, P., Monti, M., Marrocchi, M. E., Di Pietro, E., La Villa, G., Laffi, G., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00008 · Cited by 204
McAndrews, M. P., Farcnik, K., Carlen, P., Damyanovich, A., Mrkonjic, M., Jones, S., & Heathcote, E. J. (2005) · Hepatology · doi:10.1002/hep.20635 · Cited by 197
Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis
Adinolfi, L. E., Restivo, L., Zampino, R., Guerrera, B., Lonardo, A., Ruggiero, L., Riello, F., Loria, P., & Florio, A. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.01.051 · Cited by 185
Fatigue and Health-Related Quality of Life (HRQL) in Chronic Hepatitis C Virus Infection
Kallman, J., O’Neil, M. M., Larive, B., Boparai, N., Calabrese, L., & Younossi, Z. M. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9708-x · Cited by 181
Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences
Bogdanos, D., Choudhuri, K., & Vergani, D. (2001) · Liver · doi:10.1034/j.1600-0676.2001.021004225.x · Cited by 177
(2008) · Kidney International · doi:10.1038/ki.2008.83 · Cited by 176
Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms
Adinolfi, L. E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i13.3410 · Cited by 174
The effects of HCV infection and management on health-related quality of life
Younossi, Z., Kallman, J., & Kincaid, J. (2007) · Hepatology · doi:10.1002/hep.21565 · Cited by 173
Cacoub, P., Delluc, A., Saadoun, D., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.065565 · Cited by 169
Self-citationArcaini, L., Vallisa, D., Rattotti, S., Ferretti, V. V., Ferreri, A. J. M., Bernuzzi, P., Merli, M., Varettoni, M., Chiappella, A., Ambrosetti, A., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu166 · Cited by 163
B‐cell non‐Hodgkin's lymphoma and hepatitis C virus infection: A systematic review
Negri, E., Little, D., Boiocchi, M., La Vecchia, C., & Franceschi, S. (2004) · International Journal of Cancer · doi:10.1002/ijc.20205 · Cited by 158
Cognitive Dysfunction in Chronic Hepatitis C: A Review
Perry, W., Hilsabeck, R. C., & Hassanein, T. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9896-z · Cited by 154
El‐Kamary, S. S., Jhaveri, R. R., & Shardell, M. D. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir306 · Cited by 149
Weissenborn, K., Ennen, J. C., Bokemeyer, M., Ahl, B., Wurster, U., Tillmann, H., Trebst, C., Hecker, H., & Berding, G. (2006) · Gut · doi:10.1136/gut.2005.080267 · Cited by 145
Saadoun, D., Resche‐Rigon, M., Sène, D., Pérard, L., Karras, A., & Cacoub, P. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.081653 · Cited by 145
Self-citationDepression, anemia and health-related quality of life in chronic hepatitis C
Dan, A. A., Martin, L. M., Crone, C., Ong, J. P., Farmer, D. W., Wise, T. N., Robbins, S., & Younossi, Z. M. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.046 · Cited by 141
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis
Bonkovsky, H. L., Snow, K. K., Malet, P. F., Back‐Madruga, C., Fontana, R. J., Sterling, R. K., Kulig, C. C., Bisceglie, A. M. D., Morgan, T. R. M., Dienstag, J. L., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.009 · Cited by 137
Landau, D. A., Saadoun, D., Halfon, P., Martinot-Peignoux, M., Marcellin, P., Foïs, E., & Cacoub, P. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23305 · Cited by 134
Self-citationCarotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations
Petta, S., Torres, D., Fazio, G., Cammà, C., Cabibi, D., Marco, V. D., Licata, A., Marchesini, G., Mazzola, A., Parrinello, G., et al. (2011) · Hepatology · doi:10.1002/hep.25508 · Cited by 132
Gray, H., Wreghitt, T. G., STRATTON, I. M., Alexander, G., Turner, R. C., & O’Rahilly, S. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00466.x · Cited by 129
Petrarca, A., Rigacci, L., Caini, P., Colagrande, S., Romagnoli, P., Vizzutti, F., Arena, U., Giannini, C., Monti, M., Montalto, P., et al. (2010) · Blood · doi:10.1182/blood-2009-11-253948 · Cited by 127
Viral Elimination Reduces Incidence of Malignant Lymphoma in Patients with Hepatitis C
Kawamura, Y., Ikeda, K., Arase, Y., Yatsuji, H., Sezaki, H., Hosaka, T., Akuta, N., Kobayashi, M., Suzuki, F., Suzuki, Y., et al. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.06.022 · Cited by 127
Emerging evidence of hepatitis C virus neuroinvasion
Laskus, T., Radkowski, M., Adair, D. M., Wilkinson, J., Scheck, A. C., & Rakela, J. (2005) · AIDS · doi:10.1097/01.aids.0000192083.41561.00 · Cited by 127
Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas
Kelaïdi, C., Rollot, F., Park, S., Tulliez, M., Christoforov, B., Calmus, Y., Podevin, P., Bouscary, D., Sogni, P., Blanche, P., et al. (2004) · Leukemia · doi:10.1038/sj.leu.2403443 · Cited by 125
Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data
Serfaty, L., & Capeau, J. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01952.x · Cited by 118
Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C
Cacoub, P., Ratziu, V., Myers, R. P., Ghillani‐Dalbin, P., Piette, J. C., Moussalli, J., & Poynard, T. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00067-3 · Cited by 118
Self-citationHsu, C., Kao, J., Chao, Y., Lin, H., Fan, Y.-C., Huang, C.-C., & Tsai, P. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12391 · Cited by 118
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation
Giannelli, F., Moscarella, S., Giannini, C., Caini, P., Monti, M., Gragnani, L., Romanelli, R. G., Solazzo, V., Laffi, G., Villa, G. L., et al. (2003) · Blood · doi:10.1182/blood-2002-05-1537 · Cited by 116
Increased Prevalence of Carotid Atherosclerosis in Hepatitis B Virus Carriers
Ishizaka, N., Ishizaka, Y., Takahashi, E., Toda, E.-I., Hashimoto, H., Ohno, M., Nagai, R., & Yamakado, M. (2002) · Circulation · doi:10.1161/hc0902.105718 · Cited by 115
Vallat, L. D., Benhamou, Y., Gutierrez, M., Ghillani‐Dalbin, P., Hercher, C., Thibault, V., Charlotte, F., Pietté, J. C., Poynard, T., Merle‐Béral, H., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20594 · Cited by 112
Self-citationPeveling‐Oberhag, J., Crisman, G., Schmidt, A., Döring, C., Lucioni, M., Arcaini, L., Rattotti, S., Hartmann, S., Piiper, A., Hofmann, W.-P., et al. (2012) · Leukemia · doi:10.1038/leu.2012.29 · Cited by 112
Lee, J., Lin, M., Yang, Y., Lu, S., Chen, H., & Hwang, S. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.01.015 · Cited by 112
Sène, D., Limal, N., Ghillani‐Dalbin, P., Saadoun, D., Pietté, J. C., & Cacoub, P. (2006) · Rheumatology · doi:10.1093/rheumatology/kel177 · Cited by 112
Self-citationWyatt, C. M., Malvestutto, C., Coca, S. G., Klotman, P. E., & Parikh, C. R. (2008) · AIDS · doi:10.1097/qad.0b013e32830e0152 · Cited by 111
Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition
Byrnes, V., Miller, A., Lowry, D., Hill, E. N., Weinstein, C. S., Alsop, D. C., Lenkinski, R. E., & Afdhal, N. H. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.09.015 · Cited by 101
Aghemo, A., Prati, G. M., Rumi, M. G., Soffredini, R., D’Ambrosio, R., Orsi, E., Nicola, S. D., Degasperi, E., Grancini, V., & Colombo, M. (2012) · Hepatology · doi:10.1002/hep.25867 · Cited by 95
Retamozo, S., Díaz‐Lagares, C., Bosch, X., Bové, A., Brito‐Zerón, P., Gómez, M.-E., Yagüe, J., Forns, X., Cid, M. C., & Ramos‐Casals, M. (2013) · Medicine · doi:10.1097/md.0b013e3182a5cf71 · Cited by 94
Myocardial injury in patients with chronic hepatitis C infection
Maruyama, S., Koda, M., Oyake, N., Sato, H., Fujii, Y., Horie, Y., & Murawaki, Y. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.045 · Cited by 87
Increased prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection.
Özyılkan, E., & Arslan, M. (1996) · PubMed · Cited by 87
Relationship between hepatitis C and microalbuminuria: Results from the NHANES III
Liangpunsakul, S., & Chalasani, N. (2004) · Kidney International · doi:10.1111/j.1523-1755.2005.00080.x · Cited by 85
Saadoun, D., Bièche, I., Maisonobe, T., Asselah, T., Laurendeau, I., Piette, J. C., Vidaud, M., & Cacoub, P. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21270 · Cited by 83
Self-citationMarcellin, P., Chousterman, M., Fontanges, T., Ouzan, D., Rotily, M., Varastet, M., Lang, J.-P., Melin, P., Cacoub, P., & for the CheObs Study Group (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02461.x · Cited by 82
Self-citationBogdanos, D. P., Mieli‐Vergani, G., & Vergani, D. (2000) · Digestive and Liver Disease · doi:10.1016/s1590-8658(00)80266-2 · Cited by 82
Hepatitis C Virus and Atherosclerosis in Patients With Type 2 Diabetes
Fukui, M., Kitagawa, Y., Nakamura, N., & Yoshikawa, T. (2003) · JAMA · doi:10.1001/jama.289.10.1245-b · Cited by 81
Cozzi, A., Zignego, A. L., Carpendo, R., Biagiotti, T., Aldinucci, A., Monti, M., Giannini, C., Rosselli, M., Laffi, G., & Moroni, F. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00706.x · Cited by 79
Sansonno, D. E., Tucci, F. A., Ghebrehiwet, B., Lauletta, G., Peerschke, E. I. B., Conteduca, V., Russi, S., Gatti, P., Sansonno, L., & Dammacco, F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902038 · Cited by 78
Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial
Fontana, R. J., Bieliauskas, L. A., Back‐Madruga, C., Lindsay, K. L., Kronfol, Z., Lok, A. S.-F., Padmanabhan, L., & the HALT-C Trial Group (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.04.006 · Cited by 78
Increased prevalence of hepatitis C virus antibodies in patients with diabetes mellitus
Özyılkan, E., Erbas, T. A., Şimşek, C., Telatar, F., Kayhan, B., & TELATAR, H. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb01075.x · Cited by 76
Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis
Zignego, A. L., Wojcik, G. L., Cacoub, P., Visentini, M., Casato, M., Mangia, A., Latanich, R., Charles, E. D., Gragnani, L., Terrier, B., et al. (2014) · Genes and Immunity · doi:10.1038/gene.2014.41 · Cited by 74
Self-citationBoddi, M., Abbate, R., Chellini, B., Giusti, B., Solazzo, V., Sofi, F., Pratesi, G., Pratesi, C., Gensini, G., & Zignego, A. L. (2007) · Digestive and Liver Disease · doi:10.1016/s1590-8658(07)80012-0 · Cited by 73
Hepatitis C Virus Infection and Risk of Stroke: A Systematic Review and Meta-Analysis
Huang, H., Kang, R., & Zhao, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081305 · Cited by 68
Gragnani, L., Piluso, A., Giannini, C., Caini, P., Fognani, E., Monti, M., Petrarca, A., Ranieri, J., Razzolini, G., Froio, V., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30274 · Cited by 68
Vita, S. D., Quartuccio, L., & Fabris, M. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.05.005 · Cited by 65
Younossi, Z. M., & Henry, L. L. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.09.025 · Cited by 62
Improved cognitive function as a consequence of hepatitis C virus treatment*
Thein, H., Maruff, P. T., Krahn, M. D., Kaldor, J. M., Koorey, D. J., Brew, B. J., & Dore, G. J. (2007) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00505.x · Cited by 60
Uto, H., Stuver, S. O., Hayashi, K., Kumagai, K., Sasaki, F., Kanmura, S., Numata, M., Moriuchi, A., Hasegawa, S., Oketani, M., et al. (2009) · Hepatology · doi:10.1002/hep.23002 · Cited by 59
Infection as a cause of type 1 diabetes?
Christen, U., Bender, C., & von Herrath, M. G. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283533719 · Cited by 59
Presentation and Prognosis of Cardiac Involvement in Hepatitis C Virus-Related Vasculitis
Terrier, B., Karras, A., Cluzel, P., Collet, J., Sène, D., Saadoun, D., & Cacoub, P. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.09.028 · Cited by 53
Self-citationIncreased Mortality Among Persons Infected With Hepatitis C Virus
Omland, L. H., Jepsen, P., Krarup, H. B., Schønning, K., Lind, B., Kromann‐Andersen, H., Homburg, K. M., Christensen, P. B., Sørensen, H. T., & Obel, N. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.09.014 · Cited by 52
Lowry, D., Coughlan, B., McCarthy, O., & Crowe, S. F. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01188.x · Cited by 51
Atherosclerosis risk in HIV-infected patients: The influence of hepatitis C virus co-infection
Sosner, P., Wangermez, M., Chagneau-Derrode, C., Moal, G. L., & Silvain, C. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.02.027 · Cited by 49
Landau, D., Rosenzwajg, M., Saadoun, D., Klatzmann, D., & Cacoub, P. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.085910 · Cited by 49
Self-citationInfection and type 1 diabetes mellitus — A two edged sword?
Goldberg, E., & Krause, I. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.02.017 · Cited by 48
Active at night, sleepy all day – Sleep disturbances in patients with hepatitis C virus infection
Heeren, M., Sojref, F., Schuppner, R., Worthmann, H., Pflugrad, H., Tryc, A. B., Pasedag, T., & Weissenborn, K. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.030 · Cited by 46 · cited 1×
“Chronic fatigue is associated with bad sleep quality and increased nocturnal activity in patients with HCV, suggesting an alteration of sleep architecture in HCV-associated encephalopathy [Heeren et al. 2014].”
BackgroundPiquer, S., Hernández, C., Enriquez, J., Ross, A. C., Esteban, J. I., Genescà, J., Bonifacio, E. E., Puig‐Domingo, M., & Simó, R. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.111515 · Cited by 45
Saadoun, D., de Chambrun, M. P., Hermine, O., Karras, A., Choquet, S., Jégo, P., Decaux, O., & Cacoub, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21856 · Cited by 43
Self-citationKidney diseases in HIV/HCV-co-infected patients
Izzedine, H., Sène, D., Cacoub, P., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832ac36a · Cited by 39
Self-citationCacoub, P., Carrat, F., Bédossa, P., Lambert, J., Pénaranda, G., Pol, S., & Halfon, P. (2009) · Antiviral Therapy · doi:10.3851/imp1298 · Cited by 37
Self-citationHepatitis c-associated glomerualar disease in liver transplant recipients
Davis, C. L., Gretch, D. R., Perkins, J. D., Harris, A. W., Wener, M. H., Alpers, C. E., Lesniewski, R. R., Lee, W., Rosa, C. D., Johnson, R. J., et al. (1995) · Liver Transplantation and Surgery · doi:10.1002/lt.500010306 · Cited by 34
Younossi, Z. M., Stepanova, M., Mishra, A., Venkatesan, C., Henry, L. L., & Hunt, S. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12485 · Cited by 34
Saadoun, D., Bièche, I., Authier, F., Laurendeau, I., Jambou, F., Piette, J. C., Vidaud, M., Maisonobe, T., & Cacoub, P. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22456 · Cited by 31
Self-citationGiannini, C., Petrarca, A., Monti, M., Arena, U., Caini, P., Solazzo, V., Gragnani, L., Milani, S., Laffi, G., & Zignego, A. L. (2008) · Blood · doi:10.1182/blood-2007-09-112490 · Cited by 30
Snow, K. K., Bonkovsky, H. L., Fontana, R. J., Kim, H. ‐., Sterling, R. K., Bisceglie, A. M. D., Morgan, T. R. M., Dienstag, J. L., Ghany, M. G., & The HALT‐C Trial Group (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04235.x · Cited by 24
Forton, D. M. (2006) · Gut · doi:10.1136/gut.2006.100081 · Cited by 19
Hepatitis C Virus-Related Lymphomagenesis in a Mouse Model
Tsukiyama–Kohara, K., Sekiguchi, S., Kasama, Y., Salem, N. E., Machida, K., & Kohara, M. (2011) · ISRN Hematology · doi:10.5402/2011/167501 · Cited by 17
Metwalley, K. A., Farghaly, H. S., & Hafeez, H. A. A. E. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.129111 · Cited by 7
Spiegel, B. M. R., Younossi, Z. M., Hays, R. D., Revicki, D., Robbins, S., & Kanwal, F. (2005) · Hepatology · doi:10.1002/hep.20659 · Cited by 7
Cited by
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment
Gane, E., Lawitz, E., Pugatch, D., Papatheodoridis, G., Bräu, N., Brown, A., Pol, S., Leroy, V., Persico, M., Moreno, C., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704053 · Cited by 400
Heffernan, A., Cooke, G. S., Nayagam, S., Thursz, M., & Hallett, T. B. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32277-3 · Cited by 265
Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
D'souza, S., Lau, K. C., Coffin, C. S., & Patel, T. R. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i38.5759 · Cited by 257
Metadata
- Authors
- Cacoub, P., Comarmond, C., Domont, F., Savey, L., Desbois, A. C., & Saadoun, D.
- Venue
- Therapeutic Advances in Infectious Disease
- Publisher
- SAGE Publications
- Published
- 2015-05-28
- Volume
- 3
- Issue
- 1
- Pages
- 3-14
- ISSN
- 2049-9361 (ISSN-L)
- 2049-937X
- OpenAlex
- W2178730303
- Cited by
- 291
- References
- 118
- FWCI
- 15.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.